# A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery

> **NCT03943446** · PHASE2 · TERMINATED · sponsor: **Takeda** · enrollment: 34 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** TAK-018
- **DRUG:** TAK-018 Placebo

## Key facts

- **NCT ID:** NCT03943446
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-08-04
- **Primary completion:** 2022-08-25
- **Final completion:** 2022-08-25
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Sponsor decision to discontinue study due to inability to recruit the expected number of subjects within the requisite time period.
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943446, "A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03943446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*